Related Experiment Video

Updated: Aug 17, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

[Homocysteine and dementia]

H Kessler1, S Bleich, P Falkai

  • 1Universitäts-Nervenklinik und Poliklinik, Psychiatrie und Psychotherapie, Homburg/Saar. nehkes@uniklinik-saarland.de

Fortschritte Der Neurologie-Psychiatrie
|March 8, 2003
PubMed

Insights

High homocysteine levels are linked to cognitive decline and vascular issues. Lowering homocysteine through vitamin supplementation may reduce the risk and progression of cognitive disorders.

Area of Science:

  • Neurology
  • Vascular Biology
  • Nutritional Science

Context:

  • Homocysteine is recognized as a significant vascular risk factor.
  • Associations between hyperhomocysteinemia and cognitive disorders like dementia are increasingly evident.
  • Potential mechanisms include direct neurotoxicity and indirect effects related to vitamin deficiencies.

Purpose:

  • To explore the link between homocysteine and cognitive impairment.
  • To investigate the role of homocysteine in cerebrovascular diseases.
  • To evaluate the potential of vitamin supplementation in managing cognitive decline.

Summary:

  • Elevated homocysteine levels are associated with cerebral macroangiopathy and microangiopathy.
  • Hyperhomocysteinemia may contribute to cognitive disorders, including vascular dementia and Alzheimer's disease.
  • This condition could indicate deficiencies in vitamins B12, B6, or folate, or a direct neurotoxic effect of homocysteine.

Impact:

  • Homocysteine is a modifiable risk factor for cognitive impairment.
  • Early identification and intervention strategies targeting homocysteine are crucial.
  • Further research through intervention studies is warranted to confirm the efficacy of vitamin supplementation in preventing cognitive decline.

More Related Videos

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...